Induction of melanoma specific monocyte cytotoxicity in patients receiving BCG immunotherapy.
D001500:BCG Vaccine / Q000627:therapeutic use*; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D009000:Monocytes / Q000276:immunology*
D001500:BCG Vaccine